Company Concert Pharmaceuticals, Inc.
Equities
CNCE
US2060221056
Biotechnology & Medical Research
Business Summary
Number of employees: 64
Managers
Managers | Title | Age | Since |
---|---|---|---|
Roger Tung
FOU | Founder | 64 | 06-04-11 |
Marc A. Becker
DFI | Director of Finance/CFO | 52 | 18-01-03 |
Chief Tech/Sci/R&D Officer | - | 07-12-31 | |
Virginia Braman
CTO | Chief Tech/Sci/R&D Officer | - | 20-03-31 |
Nancy Stuart
COO | Chief Operating Officer | 65 | 06-06-30 |
Investor Relations Contact | - | 08-02-29 | |
Kimberly Mack
HRO | Human Resources Officer | - | 06-09-30 |
Nabil Uddin
PRN | Corporate Officer/Principal | - | 13-12-31 |
General Counsel | 47 | 19-09-22 | |
General Counsel | - | 16-09-05 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Roger Tung
FOU | Founder | 64 | 06-04-11 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 48,138,789 | 43,915,652 ( 91.23 %) | 200,601 ( 0.4167 %) | 91.23 % |
Stock B | 0 | 20,746 | 0 | 0 |
Company contact information
Concert Pharmaceuticals, Inc.
65 Hayden Avenue Suite 3000N
02421, Lexington
+781 860 0045
http://www.concertpharma.comSector
1st Jan change | Capi. | |
---|---|---|
+43.36% | 58.06B | |
-5.31% | 40.53B | |
+37.52% | 38.99B | |
+14.75% | 26.7B | |
-12.56% | 26.56B | |
-22.45% | 18.98B | |
+0.04% | 12.17B | |
+25.12% | 12B | |
+26.04% | 11.92B |